Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
- Conditions
- Interventions
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 24
- Registration Number
- NCT03224767
- Locations
- 🇺🇸
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
🇺🇸Sutter Roseville Medical Center, Roseville, California, United States
🇺🇸Eden Hospital Medical Center, Castro Valley, California, United States
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Conditions
- Interventions
- Drug: AllopurinolDrug: CytarabineDrug: Daunorubicin HydrochlorideDrug: Vincristine SulfateDrug: DexamethasoneDrug: Pegylated L-AsparaginaseDrug: MethotrexateProcedure: Bone Marrow Aspiration and BiopsyDrug: CyclophosphamideDrug: MercaptopurineBiological: RituximabDrug: ThioguanineDrug: DoxorubicinOther: Laboratory Biomarker AnalysisBiological: Inotuzumab Ozogamicin
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 310
- Registration Number
- NCT03150693
- Locations
- 🇺🇸
Alaska Women's Cancer Care, Anchorage, Alaska, United States
🇺🇸Anchorage Oncology Centre, Anchorage, Alaska, United States
🇺🇸Katmai Oncology Group, Anchorage, Alaska, United States
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 158
- Registration Number
- NCT03103321
- Locations
- 🇺🇸
Kaiser Permanente-Cadillac, Los Angeles, California, United States
🇺🇸University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 50
- Registration Number
- NCT03087708
- Locations
- 🇺🇸
Mount Carmel East Hospital, Columbus, Ohio, United States
🇺🇸Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States
🇺🇸Grant Medical Center, Columbus, Ohio, United States
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
- Conditions
- Interventions
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 3021
- Registration Number
- NCT02927249
- Locations
- 🇺🇸
Contra Costa Regional Medical Center, Martinez, California, United States
🇺🇸Ascension Providence Hospitals - Novi, Novi, Michigan, United States
🇺🇸Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States
Pulmonary Rehabilitation Before Lung Cancer Resection
- Conditions
- Interventions
- First Posted Date
- 2016-09-02
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 9
- Registration Number
- NCT02887521
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States
🇨🇦London Regional Cancer Program, London, Ontario, Canada
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
- Conditions
- Interventions
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 23
- Registration Number
- NCT02856581
- Locations
- 🇺🇸
Baptist Health Paducah, Paducah, Kentucky, United States
🇺🇸Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States
🇺🇸Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 126
- Registration Number
- NCT02839343
- Locations
- 🇺🇸
Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸Levine Cancer Institute-SouthPark, Charlotte, North Carolina, United States
🇺🇸Levine Cancer Institute-Mallard Creek, Charlotte, North Carolina, United States
Breast Cancer WEight Loss Study (BWEL Study)
- Conditions
- Interventions
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 3177
- Registration Number
- NCT02750826
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸Advocate Illinois Masonic Medical Center, Chicago, Illinois, United States
🇺🇸Rex Hematology Oncology Associates-Cary, Cary, North Carolina, United States
Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 46
- Registration Number
- NCT02749903
- Locations
- 🇺🇸
Greenville Health System Cancer Institute-Easley, Easley, South Carolina, United States
🇺🇸Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
🇺🇸Dayton Physicians LLC-Wayne, Greenville, Ohio, United States